A one-afternoon event showcasing scientific presentations by Department faculty and trainees with open discussions for applying lessons learned to attendee areas of interest.
Congratulations to Dr. Thomas Giordano and the entire Cancer Genome Atlas Project team for winning the American Association of Cancer Research's 2020 Team Science Award [...]
The research was just published in Modern Pathology and highlights the importance of next-generation sequencing within oncogenic roles for P53 and JAK/STAT signaling in microcystic adnexal carcinomas.
The research was just published in Histopathology and features prominent contributions from our faculty.
The Department of Pathology 2019 Annual Report is now available online. Our department continues to show outstanding performance and growth and the past year was another example of why our department is one of the best in the world.
In the report, you will read about [...]
Event showcases clinical and translational research.
Drs. Thomas Giordano, Paul Harms, and Dafydd Thomas have a fully staffed and highly functional Research Histology lab. The laboratories lead technician, Chelsea Decker, HT, has been keeping the lab [...]
In 2015, Felipe da Veiga Leprevost, PhD, came to the University of Michigan as a research fellow to study computational proteomics. In June of 2019, he accepted a faculty position as a Research Investigator in Bioinformatics. He now has a Michigan-born little one and his roots are growing deeper in Ann Arbor [...]
The Department of Pathology embraces the future while navigating through multiple changes as it settles into its new laboratory home.
A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.
The 10th annual CHAMP Research Day will be held on Thursday, February 7th, 2019 from 3:00 pm to 7:30 pm in the Research Auditorium located in building 10 of the North Campus Research Complex. The event will feature presentations by Department of Pathology trainees and faculty [...]
On Thursday, December 20, 2018, at 3:30 pm, the founders of InheRET, Inc., participated in the bell ringing ceremony at the University of Michigan’s Technology Transfer office. The event signaled the formal licensing of technology developed at the University of Michigan to the spin-off corporation.
InheRET, Inc., developed jointly by the Department of Pathology and the Department of Internal Medicine faculty and staff, has produced an online family health history questionnaire. It interprets patient-entered data [...]
Commitments to patient care and innovative technologies earn us top ratings.
A decade-long effort to genomically characterize multiple cancers begets a huge archive.
Clinical FISH Assays for TFE3 and TFEB Help Characterize Renal Cell Carcinoma.
Newly identified RNA protein, "THOR", plays role in cancer development and could lead to new treatment.